This protocol sets out measures for the follow-up and management of individuals exposed to infected animals and human cases of avian influenza, and for the public health management of possible and confirmed human cases.
This Reporting Protocol describes data collection for influenza, COVID-19, and other respiratory viruses (such as RSV or new viruses of public health concern) in the EU/EEA and wider WHO European Region. Data collection is integrated for most datasets in line with the operational considerations for respiratory virus surveillance in Europe.
This document is an update of the joint guidance that was published in 2011 by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
This handbook provides an overview of commonly used laboratory protocols for the characterisation of SARS-CoV-2 and influenza viruses, provided by the AURORAE consortium.
This document presents the core protocol for ECDC studies of CVE and IVE against symptomatic laboratory-confirmed influenza or SARS-CoV-2 infection, respectively, at primary care level.
Tuberculosis (TB) is a major cause of morbidity and mortality in Europe. High-quality laboratory diagnosis of TB is the basis for both individual patient treatment and surveillance.
This document provides an update on the safety of substances of human origin (SoHO) in relation to COVID-19. It reassesses the risk and proposes revised mitigation measures for preventing transmission through SoHO.
This Reporting Protocol provides guidelines for data managers in reporting countries on how to prepare data for submission to TESSy, deadlines for reporting, subject-specific information (e.g. new changes to metadata), and links to further information.
This Reporting Protocol provides guidelines for data managers in reporting countries on how to prepare data for submission to TESSy, deadlines for reporting, subject-specific information (e.g. new changes to metadata), and links to further information.